NeuroOne Medical Technologies Corporation Gain (Loss) on Disposition of Assets
NeuroOne Medical Technologies Corporation (NMTC) reported Gain (Loss) on Disposition of Assets of -$32.14 thousand for the 12-month period ending 2023-09-30, per its 10-K filed 2024-12-17.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2024-12-17
- NeuroOne Medical Technologies Corporation gain (loss) on disposition of assets for fiscal 2023 was -$32.14K.
| Period end | Gain (Loss) on Disposition of Assets 12 month |
|---|---|
| 2023-09-30 | -$32.14K 10-K · filed 2024-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |